Effects of the Menstrual Cycle on Blood Glucose Changes During Exercise in Women With Type 1 Diabetes Using Oral Contraceptives
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Female participants with type 1 diabetes using oral contraceptives will be asked to wear a continuous glucose monitor for at least three days on two separate occasions (once during the last week of active pills and once during the no pill/placebo pill phase of the menstrual cycle). An exercise session (45 minutes of aerobic exercise at 60% VO2peak on a cycle ergometer) will take place at 5 pm on the second day of glucose monitoring.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: f
View:
• type 1 diabetes diagnosed for at least 1 year
• regular menses
• using monophasic oral contraceptives
• residing in Edmonton, Alberta and able to visit the lab at the University of Alberta
Locations
Other Locations
Canada
Alberta Diabetes Institute
RECRUITING
Edmonton
Time Frame
Start Date: 2022-03-15
Estimated Completion Date: 2026-08-30
Participants
Target number of participants: 15
Treatments
Experimental: All participants
All participants will be in a single study arm.
Related Therapeutic Areas
Sponsors
Collaborators: Women and Children's Health Research Institute, Canada
Leads: University of Alberta